INTERLUDE Trademark

Trademark Overview


On Tuesday, August 6, 2024, a trademark application was filed for INTERLUDE with the United States Patent and Trademark Office. The USPTO has given the INTERLUDE trademark a serial number of 98685173. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, August 6, 2024. This trademark is owned by Merit Medical Systems, Inc.. The INTERLUDE trademark is filed in the Medical Instrument Products category with the following description:

Medical devices, namely vascular stents, balloon dilation catheters, guidewires, and snares; medical devices, namely vascular stent systems comprised of vascular stents and delivery devices sold as a unit
interlude

General Information


Serial Number98685173
Word MarkINTERLUDE
Filing DateTuesday, August 6, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, August 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical devices, namely vascular stents, balloon dilation catheters, guidewires, and snares; medical devices, namely vascular stent systems comprised of vascular stents and delivery devices sold as a unit

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, August 6, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMerit Medical Systems, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth Jordan, UT 84095

Trademark Events


Event DateEvent Description
Tuesday, August 6, 2024NEW APPLICATION ENTERED
Tuesday, August 6, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED